Guidelines for the treatment of recurrent and metastatic cervical cancer.
Although there have been important advances in the management of women with cervical cancer, the optimal treatment for patients with locally recurrent and metastatic disease is still problematic, and there are relatively few randomized trials to guide treatment decisions. This paper reviews the approach to management of patients who relapse after primary treatment for cervical cancer. Patients who are still potentially curable with radical treatment are identified, and the various treatment strategies are discussed. However, most women are treated with palliative intent, and the literature on palliative management is reviewed together with the levels of evidence.
Department of Medical Oncology, Prince of Wales Hospital, Randwick, New South Wales, Australia. m.friedlander@unsw.edu.au
Michael
M
Friedlander
Michelle
M
Grogan
D024221:Antineoplastic Protocols / Q000592:standards*; D016022:Case-Control Studies; D003657:Decision Making; D005260:Female; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D002583:Uterine Cervical Neoplasms / Q000556:secondary* / Q000628:therapy*; D016387:Women's Health